Ethnic Variability in the Plasma Exposures of OATP1B1 Substrates Such as HMG‐CoA Reductase Inhibitors: A Kinetic Consideration of Its Mechanism

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|94|1|37-51

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.94, Iss.1, 2013-07, pp. : 37-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HMG-CoA Reductase Inhibitors: Is the Endothelium the Main Target?

By  

Cardiology, Vol. 95, Iss. 1, 2001-05 ,pp. : 9-13

Karger

Access to resources Recommend Favorite

Effect of HMG-CoA Reductase Inhibitors (Statins) on Bone Mineral Density

By Funkhouser H.L.   Adera T.   Adler R.A.  

Journal of Clinical Densitometry, Vol. 5, Iss. 2, 2002-06 ,pp. : 151-158

Humana Press, Inc

Access to resources Recommend Favorite

Impact of HMG‐CoA reductase inhibitors on the incidence of polyomavirus‐associated nephropathy in renal transplant recipients with human BK polyomavirus viremia

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 536-543

John Wiley & Sons Inc

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors Reduce Nicotine-Induced Expression of Cellular Adhesion Molecules in Cultured Human Coronary Endothelial Cells

By  

Journal of Vascular Research, Vol. 44, Iss. 6, 2007-07 ,pp. : 460-470

Karger

Access to resources Recommend Favorite

Impact of OATP1B1, MDR1, and CYP3A4 Expression in Liver and Intestine on Interpatient Pharmacokinetic Variability of Atorvastatin in Obese Subjects

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 93, Iss. 3, 2013-03 ,pp. : 275-282

John Wiley & Sons Inc

Access to resources Recommend Favorite